Bioinspired Collagen/Hyaluronic Acid/Fibrin-Based Hydrogels for Soft Tissue Engineering: Design, Synthesis, and In Vitro Characterization.

collagen fibrin hyaluronic acid hydrogel spheroid tissue engineering

Journal

Journal of functional biomaterials
ISSN: 2079-4983
Titre abrégé: J Funct Biomater
Pays: Switzerland
ID NLM: 101570734

Informations de publication

Date de publication:
07 Oct 2023
Historique:
received: 10 08 2023
revised: 12 09 2023
accepted: 16 09 2023
medline: 27 10 2023
pubmed: 27 10 2023
entrez: 27 10 2023
Statut: epublish

Résumé

A major challenge for future drug development comprises finding alternative models for drug screening. The use of animal models in research is highly controversial, with an ongoing debate on their ethical acceptability. Also, animal models are often poorly predictive of therapeutic outcomes due to the differences between animal and human physiological environments. In this study, we aimed to develop a biomimetic hydrogel that replicates the composition of skin for potential use in in vitro modeling within tissue engineering. The hydrogel was fabricated through the crosslinking of collagen type I, hyaluronic acid, four-arm PEG succinimidyl glutarate (4S-StarPEG), and fibrinogen. Various ratios of these components were systematically optimized to achieve a well-interconnected porosity and desirable rheological properties. To evaluate the hydrogel's cytocompatibility, fibroblasts were embedded within the matrix. The resulting hydrogel exhibited promising properties as a scaffold, also facilitating the growth of and proliferation of the cells. This biomimetic hydrogel holds great potential for tissue engineering applications, particularly in skin regeneration and cancer research. The study used melanoma spheroids fabricated using the 96-round bottom well plate method as a potential application. The results demonstrate that the developed hydrogels allowed the maintenance of spheroid integrity and viability, meaning it has a promising use as a three-dimensional in vitro model of melanoma for both tissue engineering and drug screening applications.

Identifiants

pubmed: 37888160
pii: jfb14100495
doi: 10.3390/jfb14100495
pmc: PMC10607851
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Engineering and Physical Sciences Research Council
ID : EP/T014970/1

Références

Materials (Basel). 2019 Nov 11;12(22):
pubmed: 31717980
Mater Sci Eng C Mater Biol Appl. 2021 Sep;128:112352
pubmed: 34474900
Sci Rep. 2017 Nov 22;7(1):16033
pubmed: 29167483
Biomater Sci. 2015 Feb;3(2):336-44
pubmed: 26218124
J Biomed Mater Res B Appl Biomater. 2016 Jul;104(5):914-22
pubmed: 25952265
Curr Stem Cell Res Ther. 2008 Jan;3(1):21-31
pubmed: 18220920
Biomed Mater. 2008 Mar;3(1):015001
pubmed: 18458488
Nurs Stand. 2012 Sep 19-25;27(3):35-42
pubmed: 23248884
Nature. 2007 Feb 22;445(7130):874-80
pubmed: 17314974
Molecules. 2019 Feb 11;24(3):
pubmed: 30754615
Micron. 2011 Apr;42(3):283-9
pubmed: 21134761
J Vis Exp. 2011 Aug 03;(54):
pubmed: 21847077
Biotechnol J. 2008 Oct;3(9-10):1172-84
pubmed: 18566957
Biointerphases. 2020 Jan 02;14(6):061005
pubmed: 31896261
Acta Biomater. 2010 Oct;6(10):3957-68
pubmed: 20466086
Front Cell Dev Biol. 2021 Jul 06;9:682414
pubmed: 34295891
Nanomedicine (Lond). 2010 Apr;5(3):469-84
pubmed: 20394538
Biophys J. 2012 Sep 5;103(5):1020-7
pubmed: 23009851
Mater Sci Eng C Mater Biol Appl. 2019 Aug;101:487-498
pubmed: 31029343
Cytometry A. 2020 Apr;97(4):394-406
pubmed: 32112613
Tissue Eng Part B Rev. 2009 Jun;15(2):201-14
pubmed: 19249942
Br J Dermatol. 2000 Feb;142(2):210-22
pubmed: 10730751
Int J Biol Macromol. 2020 Dec 1;164:2186-2196
pubmed: 32758610
Mater Sci Eng C Mater Biol Appl. 2018 Aug 1;89:213-222
pubmed: 29752091
ACS Appl Mater Interfaces. 2017 Jun 21;9(24):20417-20425
pubmed: 28557435
Appl Microbiol Biotechnol. 2015 Jan;99(2):623-36
pubmed: 25432676
Biofabrication. 2018 Dec 27;11(1):015014
pubmed: 30524040
J Vis Exp. 2018 May 18;(135):
pubmed: 29863656
Tissue Eng Part B Rev. 2008 Jun;14(2):199-215
pubmed: 18544016
Micromachines (Basel). 2022 Apr 09;13(4):
pubmed: 35457892
J Med Life. 2011 May 15;4(2):172-7
pubmed: 21776301
Biotechnol Bioeng. 2009 Jul 1;103(4):655-63
pubmed: 19472329
Polymers (Basel). 2021 Nov 19;13(22):
pubmed: 34833306
Biomaterials. 2004 Jun;25(14):2789-98
pubmed: 14962557
J Mech Behav Biomed Mater. 2019 Feb;90:644-654
pubmed: 30502673
Biomaterials. 2011 Oct;32(29):7096-105
pubmed: 21741704
Tissue Eng. 2007 Jun;13(6):1299-312
pubmed: 17518741
Int J Biol Macromol. 2016 May;86:917-28
pubmed: 26893053
Anal Bioanal Chem. 2009 Oct;395(3):829-37
pubmed: 19685340
Biotechnol Bioeng. 2020 Dec;117(12):3912-3923
pubmed: 32770746
Eur J Cancer. 1997 May;33(6):926-30
pubmed: 9291817
Cells. 2021 Dec 23;11(1):
pubmed: 35011588
J Cell Physiol. 1998 Dec;177(3):465-73
pubmed: 9808154
Reproduction. 2009 Nov;138(5):813-25
pubmed: 19635739
Acta Biomater. 2022 Nov;153:13-37
pubmed: 36191774
J Invest Dermatol. 2006 Oct;126(10):2202-9
pubmed: 16741511
Sci Adv. 2015 Oct 23;1(9):e1500758
pubmed: 26601312
J Biomater Appl. 2017 Oct;32(4):511-523
pubmed: 28899224
Bioact Mater. 2021 Apr 06;6(11):3692-3704
pubmed: 33898873
J Cosmet Dermatol. 2014 Mar;13(1):44-51
pubmed: 24641605
Polymers (Basel). 2021 Jan 24;13(3):
pubmed: 33498852
J Periodontol. 2001 Feb;72(2):215-29
pubmed: 11288796
Assay Drug Dev Technol. 2019 Apr;17(3):140-149
pubmed: 30958703
Materials (Basel). 2021 Nov 08;14(21):
pubmed: 34772251
Mater Sci Eng C Mater Biol Appl. 2018 Oct 1;91:236-246
pubmed: 30033251
Biomaterials. 2006 Mar;27(9):1868-75
pubmed: 16246413
ACS Biomater Sci Eng. 2018 Mar 12;4(3):1029-1036
pubmed: 33418786
Bioact Mater. 2017 Sep 30;3(2):194-200
pubmed: 29744457
Biomed Mater. 2021 Oct 05;16(6):
pubmed: 34525462
BMC Cancer. 2013 Feb 27;13:95
pubmed: 23446043
Appl Biochem Biotechnol. 2017 May;182(1):276-293
pubmed: 27900664
J Invest Dermatol. 2001 Jan;116(1):93-101
pubmed: 11168803
Biochim Biophys Acta. 2014 Jan;1842(1):32-43
pubmed: 24161538
Curr Protoc Cell Biol. 2008 Dec;Chapter 19:Unit 19.9
pubmed: 19085986
Mater Sci Eng R Rep. 2021 Oct;146:
pubmed: 34483486
Sci Technol Adv Mater. 2011 Jul 27;12(4):045003
pubmed: 27877422
Adv Exp Med Biol. 2018;1064:253-261
pubmed: 30471038
Int J Biol Macromol. 2018 Feb;107(Pt A):93-104
pubmed: 28860056
Rom J Morphol Embryol. 2018;59(1):71-76
pubmed: 29940614
Mar Drugs. 2021 Dec 15;19(12):
pubmed: 34940707

Auteurs

Bianca Bindi (B)

School of Engineering, Newcastle University, Newcastle upon Tyne NE1 7RU, UK.

Annalisa Perioli (A)

School of Engineering, Newcastle University, Newcastle upon Tyne NE1 7RU, UK.

Priscila Melo (P)

School of Engineering, Newcastle University, Newcastle upon Tyne NE1 7RU, UK.

Clara Mattu (C)

Department of Mechanical and Aerospace Engineering, Politecnico di Torino, Corso Duca degli Abruzzi 24, 10129 Torino, Italy.

Ana Marina Ferreira (AM)

School of Engineering, Newcastle University, Newcastle upon Tyne NE1 7RU, UK.

Classifications MeSH